Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IIR-17011845Phase 4Not yet recruiting
Phase 4, open-label trial of entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Shuguang Hospital. Primary endpoints: HBsAg, HBsAb and 3 more. Planned start Mar 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IIR-17011845.